UK Markets closed

McCormick & Company, Incorporated (MKC-V)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
99.14-1.25 (-1.25%)
As of 10:00AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3107.02
52-week low 377.05
50-day moving average 399.61
200-day moving average 391.55

Share statistics

Avg vol (3-month) 32.06k
Avg vol (10-day) 31.05k
Shares outstanding 517.97M
Implied shares outstanding 6N/A
Float 8264.14M
% held by insiders 120.57%
% held by institutions 15.62%
Shares short (28 Apr 2022) 4604
Short ratio (28 Apr 2022) 40.34
Short % of float (28 Apr 2022) 40.00%
Short % of shares outstanding (28 Apr 2022) 40.00%
Shares short (prior month 30 Mar 2022) 41.25k

Dividends & splits

Forward annual dividend rate 41.48
Forward annual dividend yield 41.48%
Trailing annual dividend rate 31.33
Trailing annual dividend yield 31.32%
5-year average dividend yield 41.55
Payout ratio 450.18%
Dividend date 324 Apr 2022
Ex-dividend date 407 Apr 2022
Last split factor 22:1
Last split date 330 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 29 Nov 2021
Most-recent quarter (mrq)27 Feb 2022

Profitability

Profit margin 11.77%
Operating margin (ttm)16.88%

Management effectiveness

Return on assets (ttm)5.23%
Return on equity (ttm)17.05%

Income statement

Revenue (ttm)6.36B
Revenue per share (ttm)23.77
Quarterly revenue growth (yoy)2.80%
Gross profit (ttm)2.51B
EBITDA 1.25B
Net income avi to common (ttm)748.4M
Diluted EPS (ttm)2.82
Quarterly earnings growth (yoy)-4.30%

Balance sheet

Total cash (mrq)338.4M
Total cash per share (mrq)1.26
Total debt (mrq)5.37B
Total debt/equity (mrq)116.42
Current ratio (mrq)0.73
Book value per share (mrq)16.41

Cash flow statement

Operating cash flow (ttm)878.4M
Levered free cash flow (ttm)467.11M